Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies.


Journal

Clinical microbiology reviews
ISSN: 1098-6618
Titre abrégé: Clin Microbiol Rev
Pays: United States
ID NLM: 8807282

Informations de publication

Date de publication:
21 09 2022
Historique:
pubmed: 22 3 2022
medline: 24 9 2022
entrez: 21 3 2022
Statut: ppublish

Résumé

Despite the advent of new diagnostics, drugs and regimens, tuberculosis (TB) remains a global public health threat. A significant challenge for TB control efforts has been the monitoring of TB therapy and determination of TB treatment success. Current recommendations for TB treatment monitoring rely on sputum and culture conversion, which have low sensitivity and long turnaround times, present biohazard risk, and are prone to contamination, undermining their usefulness as clinical treatment monitoring tools and for drug development. We review the pipeline of molecular technologies and assays that serve as suitable substitutes for current culture-based readouts for treatment response and outcome with the potential to change TB therapy monitoring and accelerate drug development.

Identifiants

pubmed: 35311552
doi: 10.1128/cmr.00227-21
pmc: PMC9491169
doi:

Substances chimiques

Antitubercular Agents 0
Hazardous Substances 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0022721

Références

JCI Insight. 2020 May 21;5(10):
pubmed: 32369456
Int J Infect Dis. 2020 Jul;96:244-253
pubmed: 32353548
EBioMedicine. 2017 Nov;25:112-121
pubmed: 29100778
Thorax. 2010 Oct;65(10):863-9
pubmed: 20861290
Am J Respir Crit Care Med. 2014 Aug 15;190(4):374-83
pubmed: 24941306
Clin Infect Dis. 2016 Apr 15;62(8):995-1001
pubmed: 26908793
Eur Respir J. 2018 Nov 8;52(5):
pubmed: 30361242
J Microbiol Methods. 2001 May;45(1):41-52
pubmed: 11295196
Sci Rep. 2019 Oct 18;9(1):15000
pubmed: 31628424
Sci Rep. 2020 May 6;10(1):7647
pubmed: 32376992
J Clin Med. 2019 Dec 31;9(1):
pubmed: 31906163
Front Microbiol. 2019 Jun 26;10:1441
pubmed: 31297103
J Clin Med. 2018 Dec 17;7(12):
pubmed: 30562940
Lancet Respir Med. 2013 Aug;1(6):427-8
pubmed: 24429228
BMC Infect Dis. 2017 Apr 8;17(1):251
pubmed: 28388895
Front Microbiol. 2019 Dec 18;10:2789
pubmed: 31921004
Open Forum Infect Dis. 2018 Oct 10;5(11):ofy253
pubmed: 30474046
J Clin Invest. 2020 Nov 2;130(11):5756-5764
pubmed: 32692731
PLoS Med. 2020 May 1;17(5):e1003113
pubmed: 32357197
PLoS One. 2019 Jun 13;14(6):e0217963
pubmed: 31194793
N Engl J Med. 2021 May 6;384(18):1705-1718
pubmed: 33951360
Clin Microbiol Infect. 2020 Nov;26(11):1488-1492
pubmed: 32750539
Mol Microbiol. 2003 Jan;47(2):529-38
pubmed: 12519202
Tuberculosis (Edinb). 2020 Mar;121:101915
pubmed: 32279871
Front Microbiol. 2020 Sep 22;11:550760
pubmed: 33072011
Lancet Infect Dis. 2021 Mar;21(3):354-365
pubmed: 33508224
Int J Tuberc Lung Dis. 2010 May;14(5):560-70
pubmed: 20392348
Nat Commun. 2021 May 18;12(1):2899
pubmed: 34006838
Quant Imaging Med Surg. 2013 Apr;3(2):89-99
pubmed: 23630656
PLoS Negl Trop Dis. 2016 May 18;10(5):e0004701
pubmed: 27192147
Radiology. 2017 Aug;284(2):574-582
pubmed: 28436741
PLoS One. 2012;7(5):e36886
pubmed: 22606304
Front Immunol. 2020 Oct 08;11:566608
pubmed: 33117351
PLoS Med. 2019 Apr 12;16(4):e1002780
pubmed: 30978194
PLoS Med. 2007 Jul 24;4(7):e238
pubmed: 17676945
N Engl J Med. 2016 Sep 15;375(11):1103-5
pubmed: 27626539
J Infect. 2017 Nov;75(5):441-447
pubmed: 28804027
Expert Rev Anti Infect Ther. 2014 Feb;12(2):223-37
pubmed: 24392698
PLoS One. 2016 Aug 10;11(8):e0160062
pubmed: 27508390
Open Forum Infect Dis. 2020 Jun 06;7(7):ofaa218
pubmed: 32733976
J Antimicrob Chemother. 2015 Oct;70(10):2823-7
pubmed: 26163401
Int J Infect Dis. 2015 Mar;32:87-93
pubmed: 25809762
Ann Lab Med. 2014 May;34(3):203-9
pubmed: 24790907
Nature. 2010 Aug 19;466(7309):973-7
pubmed: 20725040
Am J Respir Crit Care Med. 2009 Sep 15;180(6):558-63
pubmed: 19542476
Expert Rev Respir Med. 2016 Jun;10(6):643-54
pubmed: 27030924
Front Immunol. 2018 Sep 28;9:2247
pubmed: 30323818
Biochem Biophys Res Commun. 2018 Sep 18;503(4):2263-2270
pubmed: 29959917
J Infect. 2017 Apr;74(4):367-376
pubmed: 28017825
Eur Respir J. 2021 Jan 5;57(1):
pubmed: 32732329
Nat Med. 2018 Nov;24(11):1708-1715
pubmed: 30397355
Korean J Intern Med. 2020 Sep;35(5):1145-1153
pubmed: 32066222
EBioMedicine. 2020 Oct;60:103007
pubmed: 32949995
Clin Nucl Med. 2016 Apr;41(4):e187-94
pubmed: 26704732
Eur Respir J. 2021 Jan 5;57(1):
pubmed: 32764113
J Clin Invest. 2015 May;125(5):1827-38
pubmed: 25822019
Chest. 2010 Jan;137(1):122-8
pubmed: 19749004
Tuberculosis (Edinb). 2017 Dec;107:48-58
pubmed: 29050771
Front Immunol. 2021 Feb 10;11:596173
pubmed: 33643286
Scand J Infect Dis. 2008;40(2):111-20
pubmed: 17852907
J Infect. 2020 Jul;81(1):57-71
pubmed: 32330526
Lancet Microbe. 2021 May;2(5):e169-e170
pubmed: 33778790
BMC Microbiol. 2016 Jul 28;16(1):167
pubmed: 27464737
J Clin Microbiol. 2015 Jun;53(6):1908-14
pubmed: 25854485
Radiology. 1993 Mar;186(3):653-60
pubmed: 8430169
J Clin Microbiol. 2019 Jun 25;57(7):
pubmed: 31018981
BMC Infect Dis. 2019 Dec 11;19(1):1048
pubmed: 31829183
Mucosal Immunol. 2021 Mar;14(2):491-499
pubmed: 32678272
Int J Infect Dis. 2019 Feb;79:65-71
pubmed: 30395979
J Clin Microbiol. 2019 Mar 28;57(4):
pubmed: 30728191
Lancet. 2018 Sep 8;392(10150):821-834
pubmed: 30215381
Int J Immunopathol Pharmacol. 2019 Jan-Dec;33:2058738419845176
pubmed: 31012357
Lancet Respir Med. 2013 Aug;1(6):462-70
pubmed: 24429244
Am J Respir Crit Care Med. 2016 Dec 15;194(12):1532-1540
pubmed: 27387272
J Clin Microbiol. 2020 Sep 22;58(10):
pubmed: 32727827
Clin Infect Dis. 2016 Oct 1;63(7):e147-e195
pubmed: 27516382
Methods Mol Biol. 2017;1616:89-105
pubmed: 28600763
JACS Au. 2021 Jul 26;1(9):1368-1379
pubmed: 34604847
Tuberculosis (Edinb). 2016 Jul;99:143-146
pubmed: 27450016
Eur J Clin Microbiol Infect Dis. 2010 Dec;29(12):1561-5
pubmed: 20820832
Cytometry A. 2020 Jul;97(7):683-693
pubmed: 32437069
J Clin Microbiol. 2014 Aug;52(8):3064-7
pubmed: 24871215
Clin Infect Dis. 2021 Nov 2;73(9):e3520-e3528
pubmed: 33070176
Ther Drug Monit. 2021 Feb 1;43(1):108-115
pubmed: 32956238
Eur Respir J. 2012 Nov;40(5):1211-20
pubmed: 22362849
J Exp Med. 1993 Dec 1;178(6):2249-54
pubmed: 7504064
Int J Tuberc Lung Dis. 2011 Jul;15(7):871-85
pubmed: 21496360
Eur Respir J. 2021 Sep 2;58(3):
pubmed: 33574078
Lancet Infect Dis. 2021 Mar;21(3):366-375
pubmed: 33508221
Sci Rep. 2020 May 25;10(1):8629
pubmed: 32451443
PLoS One. 2014 Mar 19;9(3):e92340
pubmed: 24647646
Thorax. 2008 May;63(5):440-6
pubmed: 17615085
Sci Rep. 2019 Dec 10;9(1):18669
pubmed: 31822686
N Engl J Med. 2018 Aug 30;379(9):823-833
pubmed: 30157391
Eur J Nucl Med Mol Imaging. 2009 Apr;36(4):632-9
pubmed: 19093113
Am J Respir Crit Care Med. 2021 Nov 1;204(9):1086-1096
pubmed: 34346856
EBioMedicine. 2019 Aug;46:202-214
pubmed: 31401197
Tuberculosis (Edinb). 2014 Jul;94(4):421-7
pubmed: 24863654
Sci Transl Med. 2014 Dec 3;6(265):265ra166
pubmed: 25473034
Tuberculosis (Edinb). 2019 Sep;118:101859
pubmed: 31434026
Thorax. 2020 Jul;75(7):606-608
pubmed: 32354738
PLoS One. 2012;7(10):e46191
pubmed: 23056259
Jpn J Infect Dis. 2019 Jan 23;72(1):19-22
pubmed: 30270248
Int J Tuberc Lung Dis. 2014 Mar;18(3):341-6
pubmed: 24670573
Tuberculosis (Edinb). 2016 Jul;99:131-142
pubmed: 27450015
Cytokine X. 2020 May 13;2(2):100028
pubmed: 33604556
Cochrane Database Syst Rev. 2016 May 10;(5):CD011420
pubmed: 27163343
J Clin Microbiol. 2018 Nov 27;56(12):
pubmed: 30257899
Int J Mycobacteriol. 2018 Oct-Dec;7(4):299-309
pubmed: 30531026
BMC Res Notes. 2021 Jun 30;14(1):247
pubmed: 34193258
Gates Open Res. 2017 Nov 6;1:9
pubmed: 29528048
Lancet Infect Dis. 2016 Apr;16(4):e34-46
pubmed: 27036358
Eur Respir J. 2016 Jun;47(6):1873-6
pubmed: 27076596
BMC Med. 2018 May 21;16(1):73
pubmed: 29779492
Eur Respir J. 2018 Mar 22;51(3):
pubmed: 29567725
Front Pediatr. 2019 Feb 11;7:27
pubmed: 30805325
Tuberculosis (Edinb). 2015 Dec;95(6):639-650
pubmed: 26515270
Lancet Respir Med. 2016 Mar;4(3):213-24
pubmed: 26907218
Nature. 2021 Jun;594(7862):265-270
pubmed: 34040261
J Clin Microbiol. 2015 Apr;53(4):1301-9
pubmed: 25673798
Infect Dis Rep. 2012 Jan 18;4(1):e10
pubmed: 24470917
Int J Tuberc Lung Dis. 2012 Sep;16(9):1180-5
pubmed: 22794271
Sci Rep. 2015 Oct 26;5:15615
pubmed: 26499913
Annu Rev Immunol. 2002;20:581-620
pubmed: 11861613
J Clin Microbiol. 2016 Aug;54(8):2058-67
pubmed: 27225403
Am J Respir Crit Care Med. 2004 Nov 15;170(10):1124-30
pubmed: 15374844
BMJ Open. 2015 Apr 15;5(4):e006833
pubmed: 25877271
PLoS One. 2020 Jan 3;15(1):e0227100
pubmed: 31899769
Nat Med. 2016 Oct;22(10):1094-1100
pubmed: 27595324
J Clin Microbiol. 2016 Dec;54(12):3028-3033
pubmed: 27733634
Int J Tuberc Lung Dis. 2018 Apr 1;22(4):399-406
pubmed: 29562987
J Med Microbiol. 2018 Dec;67(12):1718-1727
pubmed: 30388066
J Infect Dis. 2013 Jan 1;207(1):18-29
pubmed: 22872737
J Infect Dis. 2015 Apr 1;211 Suppl 2:S39-49
pubmed: 25765105
Appl Environ Microbiol. 2014 Oct;80(19):5884-91
pubmed: 25038100
Clin Pharmacol Ther. 2017 Aug;102(2):321-331
pubmed: 28124478
Proc Natl Acad Sci U S A. 2018 Jan 2;115(1):E62-E71
pubmed: 29255022
Indian J Tuberc. 2019 Jan;66(1):134-138
pubmed: 30797271
Genome Med. 2019 Jul 25;11(1):45
pubmed: 31345251
Eur Respir J. 2011 Dec;38(6):1398-405
pubmed: 21700601
Lancet. 2016 Jun 4;387(10035):2312-2322
pubmed: 27017310
PLoS One. 2020 Jan 24;15(1):e0224445
pubmed: 31978149
Scand J Infect Dis. 2013 Nov;45(11):825-36
pubmed: 24041274
Int J Tuberc Lung Dis. 2012 Jul;16(7):928-33
pubmed: 22583610
BMC Infect Dis. 2010 Jun 08;10:161
pubmed: 20529335
Int J Tuberc Lung Dis. 2012 Oct;16(10):1335-43
pubmed: 23107633
J Clin Microbiol. 2011 Nov;49(11):3905-11
pubmed: 21900522
Tuberculosis (Edinb). 2019 Dec;119:101864
pubmed: 31568973
J Clin Microbiol. 2021 Mar 19;59(4):
pubmed: 33536294
Respir Res. 2018 Dec 27;19(1):259
pubmed: 30587190
Sci Transl Med. 2021 Feb 3;13(579):
pubmed: 33536283
J Infect Dis. 2012 May 15;205 Suppl 2:S250-7
pubmed: 22448027
EJNMMI Res. 2020 Feb 10;10(1):8
pubmed: 32040770
Lancet Respir Med. 2015 Mar;3(3):201-9
pubmed: 25726085

Auteurs

Jan Heyckendorf (J)

Department of Medicine I, University Hospital Schleswig-Holstein, Kiel, Germany.
Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany.
German Center for Infection Research (DZIF), Braunschweig, Germany.
International Health/Infectious Diseases, University of Lübeck, Lübeck, Germany.

Sophia B Georghiou (SB)

FIND, the Global Alliance for Diagnostics, Geneva, Switzerland.

Nicole Frahm (N)

Bill & Melinda Gates Medical Research Institute, Cambridge, Massachusetts, USA.

Norbert Heinrich (N)

Division of Infectious Diseases and Tropical Medicine, Medical Centre of the University of Munich (LMU), Munich, Germany.

Irina Kontsevaya (I)

Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany.
German Center for Infection Research (DZIF), Braunschweig, Germany.
International Health/Infectious Diseases, University of Lübeck, Lübeck, Germany.

Maja Reimann (M)

Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany.
German Center for Infection Research (DZIF), Braunschweig, Germany.
International Health/Infectious Diseases, University of Lübeck, Lübeck, Germany.

David Holtzman (D)

FIND, the Global Alliance for Diagnostics, Geneva, Switzerland.

Marjorie Imperial (M)

University of California San Francisco, San Francisco, California, USA, United States.

Daniela M Cirillo (DM)

Emerging Bacterial Pathogens Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Stephen H Gillespie (SH)

School of Medicine, University of St Andrewsgrid.11914.3c, St Andrews, Fife, Scotland.

Morten Ruhwald (M)

FIND, the Global Alliance for Diagnostics, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH